Skip to main content
Log in

Reduced recurrence-free survival after reduced doses of adjuvant chemotherapy in breast cancer: Are groups selected after randomization comparable?

  • Correspondence
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambilla C, Zambetti M, Veronesi U: Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 5, 95–115, 1985

    PubMed  Google Scholar 

  2. Bonadonna G, Valagussa P: Dose-response effect of adjuvant chemotherapy in breast cancer. New Engl J Med 304: 10–15, 1981

    PubMed  Google Scholar 

  3. Redmond C, Fisher B, Wieand HS: The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with diseasefree survival. Cancer Treat Reports 67: 519–526, 1983

    Google Scholar 

  4. Frei E, Canellos GP: Dose: a critical factor in cancer chemotherapy. Am J Med 69: 585–594, 1980

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rutqvist, L.E., Wallgren, A. & Wennerholm, AC. Reduced recurrence-free survival after reduced doses of adjuvant chemotherapy in breast cancer: Are groups selected after randomization comparable?. Breast Cancer Res Tr 7, 45–46 (1986). https://doi.org/10.1007/BF01886735

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01886735

Keywords

Navigation